PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIOPX vs. BPTRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


BIOPXBPTRX
YTD Return7.34%-13.28%
1Y Return41.57%14.41%
3Y Return (Ann)-1.94%-4.75%
5Y Return (Ann)16.72%23.04%
10Y Return (Ann)16.08%16.90%
Sharpe Ratio2.180.47
Daily Std Dev20.06%25.27%
Max Drawdown-67.79%-65.33%
Current Drawdown-21.98%-35.22%

Correlation

-0.50.00.51.00.7

The correlation between BIOPX and BPTRX is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

BIOPX vs. BPTRX - Performance Comparison

In the year-to-date period, BIOPX achieves a 7.34% return, which is significantly higher than BPTRX's -13.28% return. Over the past 10 years, BIOPX has underperformed BPTRX with an annualized return of 16.08%, while BPTRX has yielded a comparatively higher 16.90% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
31.49%
5.46%
BIOPX
BPTRX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Baron Opportunity Fund

Baron Partners Fund

BIOPX vs. BPTRX - Expense Ratio Comparison

BIOPX has a 1.31% expense ratio, which is lower than BPTRX's 1.36% expense ratio.


BPTRX
Baron Partners Fund
Expense ratio chart for BPTRX: current value at 1.36% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.36%
Expense ratio chart for BIOPX: current value at 1.31% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.31%

Risk-Adjusted Performance

BIOPX vs. BPTRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Baron Opportunity Fund (BIOPX) and Baron Partners Fund (BPTRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIOPX
Sharpe ratio
The chart of Sharpe ratio for BIOPX, currently valued at 2.18, compared to the broader market-1.000.001.002.003.004.002.18
Sortino ratio
The chart of Sortino ratio for BIOPX, currently valued at 2.86, compared to the broader market-2.000.002.004.006.008.0010.0012.002.86
Omega ratio
The chart of Omega ratio for BIOPX, currently valued at 1.36, compared to the broader market0.501.001.502.002.503.001.36
Calmar ratio
The chart of Calmar ratio for BIOPX, currently valued at 0.98, compared to the broader market0.002.004.006.008.0010.0012.000.98
Martin ratio
The chart of Martin ratio for BIOPX, currently valued at 7.75, compared to the broader market0.0010.0020.0030.0040.0050.0060.007.75
BPTRX
Sharpe ratio
The chart of Sharpe ratio for BPTRX, currently valued at 0.47, compared to the broader market-1.000.001.002.003.004.000.47
Sortino ratio
The chart of Sortino ratio for BPTRX, currently valued at 0.82, compared to the broader market-2.000.002.004.006.008.0010.0012.000.82
Omega ratio
The chart of Omega ratio for BPTRX, currently valued at 1.10, compared to the broader market0.501.001.502.002.503.001.10
Calmar ratio
The chart of Calmar ratio for BPTRX, currently valued at 0.27, compared to the broader market0.002.004.006.008.0010.0012.000.27
Martin ratio
The chart of Martin ratio for BPTRX, currently valued at 0.90, compared to the broader market0.0010.0020.0030.0040.0050.0060.000.90

BIOPX vs. BPTRX - Sharpe Ratio Comparison

The current BIOPX Sharpe Ratio is 2.18, which is higher than the BPTRX Sharpe Ratio of 0.47. The chart below compares the 12-month rolling Sharpe Ratio of BIOPX and BPTRX.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2024FebruaryMarchApril
2.18
0.47
BIOPX
BPTRX

Dividends

BIOPX vs. BPTRX - Dividend Comparison

Neither BIOPX nor BPTRX has paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
BIOPX
Baron Opportunity Fund
0.00%0.00%0.00%8.71%6.96%7.33%5.28%15.58%13.52%10.92%5.66%6.13%
BPTRX
Baron Partners Fund
0.00%0.00%3.19%7.72%3.67%0.26%0.00%0.00%0.00%0.35%0.00%0.00%

Drawdowns

BIOPX vs. BPTRX - Drawdown Comparison

The maximum BIOPX drawdown since its inception was -67.79%, roughly equal to the maximum BPTRX drawdown of -65.33%. Use the drawdown chart below to compare losses from any high point for BIOPX and BPTRX. For additional features, visit the drawdowns tool.


-40.00%-35.00%-30.00%-25.00%-20.00%NovemberDecember2024FebruaryMarchApril
-21.98%
-35.22%
BIOPX
BPTRX

Volatility

BIOPX vs. BPTRX - Volatility Comparison

The current volatility for Baron Opportunity Fund (BIOPX) is 6.29%, while Baron Partners Fund (BPTRX) has a volatility of 7.39%. This indicates that BIOPX experiences smaller price fluctuations and is considered to be less risky than BPTRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%NovemberDecember2024FebruaryMarchApril
6.29%
7.39%
BIOPX
BPTRX